Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Interferon regulatory factor 1 (IRF1) regulates diverse biological functions, including modulation of cellular responses involved in tumorigenesis. Genetic mutations and altered IRF1 function are associated with several cancers. Although the function of IRF1 in the immunobiology of cancer is emerging, IRF1-specific mechanisms regulating tumorigenesis and tissue homeostasis in vivo are not clear. Here, we found that mice lacking IRF1 were hypersusceptible to colorectal tumorigenesis. IRF1 functions in both the myeloid and epithelial compartments to confer protection against AOM/DSS-induced colorectal tumorigenesis. We further found that IRF1 also prevents tumorigenesis in a spontaneous mouse model of colorectal cancer. The attenuated cell death in the colons of Irf1-/- mice was due to defective pyroptosis, apoptosis, and necroptosis (PANoptosis). IRF1 does not regulate inflammation and the inflammasome in the colon. Overall, our study identified IRF1 as an upstream regulator of PANoptosis to induce cell death during colitis-associated tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686 · cited 1×
“Pyroptosis is mediated by gasdermin D (GSDMD) cleavage upon inflammasome activation (23), whereas necroptosis is mediated by mixed lineage kinase domain-like pseudokinase (MLKL) upon activation of its upstream kinases receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and RIPK3 (24).”
BackgroundA pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Molecular mechanisms of necroptosis: an ordered cellular explosion
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2970 · Cited by 2,382 · cited 1×
“For instance, upon CASP8 inhibition, the activity of RIPK3 is increased, and cells undergo necroptosis (25).”
BackgroundBroad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Xia, X., Wang, X., Cheng, Z., Qin, W., Lei, L., Jiang, J., & Hu, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1883-8 · Cited by 856
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 844
Kuriakose, T., Man, S. M., Subbarao Malireddi, R. K., Karki, R., Kesavardhana, S., Place, D. E., Neale, G., Vogel, P., & Kanneganti, T.-D. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag2045 · Cited by 818 · cited 2×
“We have previously found that IRF1 mediates NLRP3 and AIM2 inflammasome activation during microbial infection (4, 7, 8).”
BackgroundSelf-citationThe role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Chen, X., Li, W., Ren, J., Huang, D., He, W.-T., Song, Y., Yang, C., Li, W., Zheng, X., Chen, P., et al. (2014) · Cell Research · doi:10.1038/cr.2013.171 · Cited by 779
Malireddi, R. K. S., Kesavardhana, S., & Kanneganti, T.-D. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00406 · Cited by 741
Self-citationActivity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
Newton, K., Dugger, D. L., Wickliffe, K. E., Kapoor, N., de Almagro, M. C., Vucic, D., Komuves, L., Ferrando, R. E., French, D. M., Webster, J., et al. (2014) · Science · doi:10.1126/science.1249361 · Cited by 687
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Self-citationPyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages
Taabazuing, C. Y., Okondo, M. C., & Bachovchin, D. A. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.03.009 · Cited by 620
Gurung, P., Anand, P. K., Malireddi, R. K. S., Vande Walle, L., Van Opdenbosch, N., Dillon, C. P., Weinlich, R., Green, D. R., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302839 · Cited by 558
Self-citationCaspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
Zheng, M., Karki, R., Vogel, P., & Kanneganti, T.-D. (2020) · Cell · doi:10.1016/j.cell.2020.03.040 · Cited by 530
Self-citationCaspase-dependent Cleavage of Signaling Proteins during Apoptosis
Widmann, C., Gibson, S., & Johnson, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7141 · Cited by 424
Zaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002046 · Cited by 411
Self-citationMan, S. M., Karki, R., Malireddi, R. K. S., Neale, G., Vogel, P., Yamamoto, M., Lamkanfi, M., & Kanneganti, T.-D. (2015) · Nature Immunology · doi:10.1038/ni.3118 · Cited by 380
Self-citationKarki, R., Man, S. M., & Kanneganti, T.-D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0269 · Cited by 377
Self-citationStromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
Tsujino, T., Seshimo, I., Yamamoto, H., Ngan, C. Y., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura, N., & Monden, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2191 · Cited by 352
Cancer therapy in the necroptosis era
Su, Z., Yang, Z., Xie, L., DeWitt, J. P., & Chen, Y. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.8 · Cited by 333
Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
Man, S. M., Zhu, Q., Zhu, L., Liu, Z., Karki, R., Malik, A., Sharma, D., Li, L., Malireddi, R. K. S., Gurung, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.001 · Cited by 327
Self-citationCooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M., & Taniguchi, T. (1996) · Nature · doi:10.1038/382816a0 · Cited by 324
Dietary modulation of the microbiome affects autoinflammatory disease
Lukens, J. R., Gurung, P., Vogel, P., Johnson, G. R., Carter, R. A., McGoldrick, D. J., Bandi, S. R., Calabrese, C. R., Walle, L. V., Lamkanfi, M., et al. (2014) · Nature · doi:10.1038/nature13788 · Cited by 314 · cited 1×
“Genetic evidence for the crosstalk among pyroptosis, apoptosis, and necroptosis has also been shown in autoinflammatory disease (32).”
BackgroundSelf-citationLabi, V, & Erlacher, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.20 · Cited by 295
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Plati, J., Bucur, O., & Khosravi‐Far, R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21707 · Cited by 293
Fujita, T., Reis, L. F., Watanabe, N., Kimura, Y., Taniguchi, T., & Vilcek, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9936 · Cited by 287
TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation
Malireddi, R. K. S., Gurung, P., Mavuluri, J., Dasari, T. K., Klco, J. M., Chi, H., & Kanneganti, T.-D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171922 · Cited by 247
Self-citationNLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Karki, R., Man, S. M., Malireddi, R. K. S., Kesavardhana, S., Zhu, Q., Burton, A. R., Sharma, B. R., Qi, X., Pelletier, S., Vogel, P., et al. (2016) · Nature · doi:10.1038/nature20597 · Cited by 213
Self-citationMesenchymal Cells in Colon Cancer
Koliaraki, V., Pallangyo, C. K., Greten, F. R., & Kollias, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.049 · Cited by 199
Targeting Programmed Cell Death Using Small‐Molecule Compounds to Improve Potential Cancer Therapy
Ke, B., Tian, M., Li, J., Liu, B., & He, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21398 · Cited by 185
IRF2 transcriptionally induces GSDMD expression for pyroptosis
Kayagaki, N., Lee, B. L., Stowe, I. B., Kornfeld, O. S., O'Rourke, K., Mirrashidi, K. M., Haley, B., Watanabe, C., Roose-Girma, M., Modrusan, Z., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aax4917 · Cited by 183
Bouker, K. B., Skaar, T. C., Riggins, R. B., Harburger, D. S., Fernández, D., Zwart, A. L., Wang, A., & Clarke, R. C. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi113 · Cited by 159
Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Safa, A. R. (2016) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2016016976 · Cited by 152
Regulation of the expression and processing of caspase-12
Kalai, M., Lamkanfi, M., Denecker, G., Boogmans, M., Lippens, S., Meeus, A., Declercq, W., & Vandenabeele, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303157 · Cited by 138
Review: IRF-1 as a Negative Regulator of Cell Proliferation
Romeo, G., Fiorucci, G., Chiantore, M. V., Percario, Z. A., Vannucchi, S., & Affabris, E. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452647 · Cited by 135
An overview of apoptosis and the prevention of colorectal cancer
Watson, A. J. M. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.06.005 · Cited by 119
Penninger, J. M., Sirard, C., Mittrücker, H., Chidgey, A. P., Kozieradzki, I., Nghiem, M. P., Hakem, A., Kimura, T., Timms, E. M., Boyd, R. L., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80527-0 · Cited by 118
Kim, P., Armstrong, M., Liu, Y., Yan, P., Bucher, B. T., Zuckerbraun, B., Gambotto, A., Billiar, T., & Yim, J. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207023 · Cited by 115
Harada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M. S., Hirai, H., & Taniguchi, T. (1994) · PubMed · Cited by 114
Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y. A., Terashima, M., Saito, K., & Satodate, R. (1996) · PubMed · Cited by 105
Gao, J., Senthil, M., Ren, B., Yan, J., Xing, Q., Yu, J., Zhang, L., & Yim, J. H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.156 · Cited by 99
Activation of Pyroptotic Cell Death Pathways in Cancer: An Alternative Therapeutic Approach
Kanipandian, N., Kannan, S., Thorne, R. F., Li, D., & Li, D. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.04.010 · Cited by 92
Common deleted region on the long arm of chromosome 5 in esophageal carcinoma
Ogasawara, S., Tamura, G., Maesawa, C., Suzuki, Y. A., Ishida, K., Satoh, N., Uesugi, N., Saito, K., & Satodate, R. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536888 · Cited by 89
Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice
He, G.-W., Günther, C., Thonn, V., Yu, Y., Martini, E., Buchen, B., Neurath, M. F., Stürzl, M., & Becker, C. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160442 · Cited by 76
Interferon regulatory factor‐1 mediates interferon‐γ‐induced apoptosis in ovarian carcinoma cells
Kim, E., Lee, J.-M., Namkoong, S., Um, S., & Park, J. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10142 · Cited by 75
Briard, B., Karki, R., Malireddi, R. K. S., Bhattacharya, A., Place, D. E., Mavuluri, J., Peters, J. L., Vogel, P., Yamamoto, M., & Kanneganti, T. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0298-0 · Cited by 75
Self-citationPizzoferrato, E., Liu, Y., Gambotto, A. A., Armstrong, M. J., Stang, M. T., Gooding, W. E., Alber, S. M., Shand, S. H., Watkins, S. C., Storkus, W. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2223 · Cited by 63
Complete Suppression of Insulitis and Diabetes in NOD mice Lacking Interferon Regulatory Factor-1
NAKAZAWA, T., Satoh, J., Takahashi, K., Sakata, Y., Ikehata, F., Takizawa, Y., Bando, S.-I., Housai, T., Li, Y., Chen, C., et al. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0531 · Cited by 60
Stang, M. T., Armstrong, M. J., Watson, G. A., Sung, K. Y., Liu, Y., Ren, B., & Yim, J. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210470 · Cited by 55
Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis
Chen, F., Jiang, G., Xu, K., & Zheng, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.1051 · Cited by 46
Tzoanopoulos, D., Speletas, M. G., Arvanitidis, K. I., Veiopoulou, C., Kyriaki, S., Thyphronitis, G., Sideras, P., Kartalis, G., & Ritis, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03829.x · Cited by 39
Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice
Sharma, B. R., Karki, R., Lee, E., Zhu, Q., Gurung, P., & Kanneganti, T. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0159-7 · Cited by 33
Self-citationBuch, T., Uthoff‐Hachenberg, C., & Waisman, A. (2003) · International Immunology · doi:10.1093/intimm/dxg086 · Cited by 32
Bouker, K. B., Skaar, T. C., Harburger, D. S., Riggins, R. B., Fernández, D., Zwart, A. L., & Clarke, R. C. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.12.008 · Cited by 17
Cited by
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734
“IRF1 has previously been shown to regulate cell death in other studies, including the induction of PANoptosis to suppress colorectal tumorigenesis (Benaoudia et al., 2019; Karki et al., 2020; Kayagaki et al., 2019; Kuriakose et al., 2018; Man et al., 2015).”
Self-citationNLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
Self-citationInnate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
Self-citationZheng, M., & Kanneganti, T. (2020) · Immunological Reviews · doi:10.1111/imr.12909 · Cited by 586
Self-citationWang, Y., & Kanneganti, T.-D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.038 · Cited by 545
“In addition to the examples discussed above, PANoptosis has been observed in many different conditions, such as during both genetic-and Yersinia YopJ-mediated inhibition of TAK1 [25,35,36], other bacterial, viral and fungal infections [23,24,26], cytokine storm [29] and cancer [28].”
BackgroundSelf-citation
Metadata
- Authors
- Karki, R., Sharma, B. R., Lee, E., Banoth, B., Malireddi, R. K. S., Samir, P., Tuladhar, S., Mummareddy, H., Burton, A. R., Vogel, P., & Kanneganti, T.-D.
- Venue
- JCI Insight
- Published
- 2020-06-18
- Volume
- 5
- Issue
- 12
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W3035771130
- Cited by
- 282
- References
- 57
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.